The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Pharmacologic Treatment of Attention Deficit–Hyperactivity Disorder
Abstract
Amphetamines and methylphenidate and, less often, nonstimulants (atomoxetine, clonidine, and guanfacine) are used to treat ADHD. Inattentiveness and restlessness are improved more than quality-of-life measures in short-term trials.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pharmacologic treatment is based on stimulants [amphetamines, such as the prodrug lisdexamfetamine dimesylate (LDX), and methylphenidate (MPH)] and nonstimulants (atomoxetine, guanfacine, clonidine, bupropion, modafinil) [17].”
From Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review (2022) · cites this paper as [17]
In the citing paper
“Stimulants have generally been used as first-line pharmacologic treatment owing to a higher efficacy in symptomatology reduction compared to nonstimulant medications in all groups of age (children, adolescents and adults) [17, 33, 34].”
From Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review (2022) · cites this paper as [17]
Citations
Cites
Polanczyk, G. V., Willcutt, E. G., Salum, G. A., Kieling, C., & Rohde, L. A. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyt261 · Cited by 1,822
Wolraich, M. L., Hagan, J. F., Allan, C., Chan, E., Davison, D., Earls, M., Evans, S. W., Flinn, S. K., Froehlich, T., Frost, J., et al. (2019) · Pediatrics · doi:10.1542/peds.2019-2528 · Cited by 1,562
Attention-deficit/hyperactivity disorder
Faraone, S. V., Asherson, P., Banaschewski, T., Biederman, J., Buitelaar, J. K., Ramos-Quiroga, J. A., Rohde, L. A., Sonuga-Barke, E. J. S., Tannock, R., & Franke, B. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.20 · Cited by 1,479
Cortese, S., Adamo, N., Del Giovane, C., Mohr-Jensen, C., Hayes, A. J., Carucci, S., Atkinson, L. Z., Tessari, L., Banaschewski, T., Coghill, D., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30269-4 · Cited by 1,402
Self-citationHart, H., Radua, J., Nakao, T., Mataix-Cols, D., & Rubia, K. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.277 · Cited by 764
Hoogman, M., Muetzel, R., Guimaraes, J. P., Shumskaya, E., Mennes, M., Zwiers, M. P., Jahanshad, N., Sudre, G., Wolfers, T., Earl, E. A., et al. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.18091033 · Cited by 467
Leucht, S., Hierl, S., Kissling, W., Dold, M., & Davis, J. M. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.096594 · Cited by 451
Cortese, S., Holtmann, M., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Dittmann, R. W., Graham, J., Taylor, E., Sergeant, J., et al. (2013) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12036 · Cited by 336
Self-citationRubia, K., Alegria, A. A., Cubillo, A. I., Smith, A. B., Brammer, M. J., & Radua, J. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.10.016 · Cited by 315
Raman, S. R., Man, K. K. C., Bahmanyar, S., Bérard, A., Bilder, S., Boukhris, T., Bushnell, G., Crystal, S., Furu, K., KaoYang, Y.-H., et al. (2018) · Lancet psychiatry · doi:10.1016/s2215-0366(18)30293-1 · Cited by 285
Liddle, E. B., Hollis, C., Batty, M. J., Groom, M. J., Totman, J. J., Liotti, M., Scerif, G., & Liddle, P. F. (2011) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2010.02333.x · Cited by 281
Attention Deficit–Hyperactivity Disorder in Children and Adolescents
Feldman, H. M., & Reiff, M. I. (2014) · New England Journal of Medicine · doi:10.1056/nejmcp1307215 · Cited by 245
Faraone, S. V., Rostain, A. L., Montano, C. B., Mason, O., Antshel, K. M., & Newcorn, J. H. (2020) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2019.06.012 · Cited by 225
Chang, Z., Ghirardi, L., Quinn, P. D., Asherson, P., D’Onofrio, B. M., & Larsson, H. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.04.009 · Cited by 175
Methyiphenidate vs. amphetamine: Comparative review
Arnold, L. E. (2000) · Journal of Attention Disorders · doi:10.1177/108705470000300403 · Cited by 164
Zetterqvist, J., Asherson, P., Halldner, L., Långström, N., & Larsson, H. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12004 · Cited by 155
KRATOCHVIL, C. J., WILENS, T. E., GREENHILL, L. L., GAO, H., BAKER, K. D., FELDMAN, P. D., & GELOWITZ, D. L. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000222788.34229.68 · Cited by 150
Mick, E. O., McManus, D. D., & Goldberg, R. J. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.06.011 · Cited by 136
Coghill, D., Banaschewski, T., Soutullo, C. A., Cottingham, M. G., & Zuddas, A. (2017) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-017-0986-y · Cited by 136
Growth on stimulant medication; clarifying the confusion: a review
Poulton, A. (2005) · Archives of Disease in Childhood · doi:10.1136/adc.2004.056952 · Cited by 129
Blood Pressure and Heart Rate Over 10 Years in the Multimodal Treatment Study of Children With ADHD
Vitiello, B., Elliott, G. R., Swanson, J. M., Arnold, L. E., Hechtman, L. T., Abikoff, H., Molina, B. S. G., Wells, K., Wigal, T. L., Jensen, P. S., et al. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10111705 · Cited by 106
Matthijssen, A. M., Dietrich, A., Bierens, M., Deters, R. K., van de Loo-Neus, G. H. H., van den Hoofdakker, B. J., Buitelaar, J. K., & Hoekstra, P. J. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.18111296 · Cited by 90
Association of ADHD medications with the risk of cardiovascular diseases: a meta-analysis
Liu, H., Feng, W., & Zhang, D. (2018) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-018-1217-x · Cited by 72
Greenhill, L. L., Swanson, J. M., Hechtman, L. T., Waxmonsky, J. G., Arnold, L. E., Molina, B. S. G., Hinshaw, S. P., Jensen, P. S., Abikoff, H., Wigal, T. L., et al. (2019) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2019.06.019 · Cited by 69
Li, L., Sujan, A. C., Butwicka, A., Chang, Z., Cortese, S., Quinn, P. D., Viktorin, A., Öberg, A. S., D'Onofrio, B. M., & Larsson, H. (2020) · CNS Drugs · doi:10.1007/s40263-020-00728-2 · Cited by 45
Self-citationTsujii, N., Okada, T., Usami, M., Kuwabara, H., Fujita, J., Negoro, H., Kawamura, M., Iida, J., & Saito, T. (2020) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.19r13015 · Cited by 31
Research works printed but not linked: 2
- Gajria K, Lu M, Sikirica V, et al. Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder — a systematic literature review. Neuropsychiatr Dis Treat 2014;10:1543-1569.25187718
- Faraone SV, Biederman J, Morley CP, Spencer TJ. Effect of stimulants on height and weight: a review of the literature. J Am Acad Child Adolesc Psychiatry 2008;47:994-1009.18580502
Cited by
Sorted by citations
Attention-deficit/hyperactivity disorder
Faraone, S. V., Bellgrove, M. A., Brikell, I., Cortese, S., Hartman, C. A., Hollis, C., Newcorn, J. H., Philipsen, A., Polanczyk, G. V., Rubia, K., et al. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00495-0 · Cited by 355
Self-citationAttention-Deficit/Hyperactivity Disorder Medications and Long-Term Risk of Cardiovascular Diseases
Zhang, L., Li, L., Andell, P., Garcia‐Argibay, M., Quinn, P. D., D'Onofrio, B. M., Brikell, I., Kuja‐Halkola, R., Lichtenstein, P., Johnell, K., et al. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.4294 · Cited by 159
ADHD Pharmacotherapy and Mortality in Individuals With ADHD
Li, L., Zhu, N., Zhang, L., Kuja‐Halkola, R., D'Onofrio, B. M., Brikell, I., Lichtenstein, P., Cortese, S., Larsson, H., & Chang, Z. (2024) · JAMA · doi:10.1001/jama.2024.0851 · Cited by 131
Self-citationAn overview on neurobiology and therapeutics of attention-deficit/hyperactivity disorder
da Silva, B. S., Grevet, E. H., Silva, L. C. F., Ramos, J. K. N., Rovaris, D. L., & Bau, C. H. D. (2023) · Discover Mental Health · doi:10.1007/s44192-022-00030-1 · Cited by 146
Li, L., Chang, Z., Sun, J., Garcia‐Argibay, M., Rietz, E. D., Dobrosavljevic, M., Brikell, I., Jernberg, T., Solmi, M., Cortese, S., et al. (2022) · World Psychiatry · doi:10.1002/wps.21020 · Cited by 110
Self-citation
Metadata
- Authors
- Cortese, S.
- Affiliations
- University of Nottingham (GB)
- Corresponding author
- Cortese, Samuele
- ORCID
- Cortese, Samuele
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2020-09-10
- Volume
- 383
- Issue
- 11
- Pages
- 1050-1056
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3084409057
- Cited by
- 342
- References
- 26
- Citations by year
- 2026: 60 · 2025: 43 · 2024: 52 · 2023: 61 · 2022: 65 · 2021: 56 · 2020: 5
- FWCI
- 7.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Social Sciences › Psychology › Neuropsychology and Physiological Psychology › Developmental and Educational Neuropsychology
- Keywords
- attention deficit hyperactivity disorder, pharmacotherapy, amphetamine, methylphenidate, atomoxetine, clonidine, guanfacine, stimulants, non-stimulant medication, inattention, restlessness, quality of life
- MeSH terms
- Atomoxetine Hydrochloride, Adolescent, Adult, Amphetamines, Attention Deficit Disorder with Hyperactivity, Child, Child, Preschool, Growth, Heart Rate, Humans, Hypertension, Methylphenidate, Patient Dropouts, Polymers, Guanfacine, Treatment Outcome, Practice Guidelines as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
